SkyAI, Inc.
NASDAQ:STSS · NASDAQ Capital Market
+$0.14 today
Vol 0.02M · Avg 0.37M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-106.9%
avg -195.7%
ROIC
-137.0%
avg -153.9%
ROA
-105.0%
avg -121.4%
Analysis
ROA is currently the strongest return metric at -105.0% versus its period average of -121.4%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Paul Kruger Danner | Executive Chairman and Principal Executive & Financial Officer | $1.32M | — | 68 | $400,000.00 | 0.95% |
Yuwen Zhang | Chief Investment Officer & Director | $212,500.00 | — | 34 | $14,040.00 | 0.03% |
Arthur R. Levine | Interim Chief Financial Officer | — | — | 67 | $40,000.00 | 0.09% |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
8
$5.13M
Sells
22
$2.23M
Net Sentiment
+$2.90M
Net buying
Most Active
Ruemler Timothy James
16 transactions
1–10 of 30
Analysis
Insiders reported 8 buys worth $5.13M and 22 sells worth $2.23M over the last 12 months. That adds up to net buying of $2.90M. Ruemler Timothy James was the most active insider with 16 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A0 analysts |
| Revenue | N/A | N/A | N/A | N/A1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Analysis will appear once historical growth or forward estimates are available for this company.
Competitors
Peer companies in the same sector
Greenwich LifeSciences, Inc.
NASDAQ:GLSI
$343.62M
Pro-Dex, Inc.
NASDAQ:PDEX
$203.44M
The Joint Corp.
NASDAQ:JYNT
$131.43M
Lucid Diagnostics Inc.
NASDAQ:LUCD
$102.30M
CareCloud, Inc.
NASDAQ:CCLD
$95.18M
Cognition Therapeutics, Inc.
NASDAQ:CGTX
$89.03M
Microbot Medical Inc.
NASDAQ:MBOT
$82.94M
Rapid Micro Biosystems, Inc.
NASDAQ:RPID
$77.95M
Sera Prognostics, Inc.
NASDAQ:SERA
$70.27M
Incannex Healthcare Limited
IXHL
$43.91M
Who manages STSS?
SkyAI, Inc. (STSS) lists 3 active executives. The top listed executive is Yuwen Zhang, Chief Investment Officer & Director.
Are STSS insiders buying or selling?
Recent insider activity shows net buying of $3.85M.
Explore More
Continue the stock analysis
Jump to another research area for this company.